Cargando…

A Novel CD73 Inhibitor SHR170008 Suppresses Adenosine in Tumor and Enhances Anti-Tumor Activity with PD-1 Blockade in a Mouse Model of Breast Cancer

INTRODUCTION: CD73 and adenosine support growth-promoting neovascularization, metastasis, and survival in cells, and promote anti-PD-1 mAb therapy-induced immune escape. Consequently, developing a CD73 inhibitor as monotherapy and a potential beneficial combination partner with immune-checkpoint inh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Suxing, Li, Di, Liu, Jian, Wang, Huiyun, Horecny, Ivana, Shen, Ru, Zhang, Rumin, Wu, Heping, Hu, Qiyue, Zhao, Peng, Zhang, Fengqi, Yan, Yinfa, Feng, Jun, Zhuang, Linghang, Li, Jing, Zhang, Lianshan, Tao, Weikang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403083/ https://www.ncbi.nlm.nih.gov/pubmed/34466002 http://dx.doi.org/10.2147/OTT.S326178

Ejemplares similares

SHR1032, a novel STING agonist, stimulates anti-tumor immunity and directly induces AML apoptosis
por: Song, Chunying, et al.
Publicado: (2022)

Discovery of a novel RORγ antagonist with skin-restricted exposure for topical treatment of mild to moderate psoriasis
por: Liu, Suxing, et al.
Publicado: (2021)

Discovery of SHR9352: A Highly Potent G Protein-Biased μ-Opioid Receptor Agonist
por: Li, Xin, et al.
Publicado: (2017)

Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer
por: Kowash, Ryan R., et al.
Publicado: (2023)

CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth
por: Allard, Bertrand, et al.
Publicado: (2012)

Activation of adenosine receptors improves renal antioxidant status in diabetic Wistar but not SHR rats
por: Patinha, Daniela, et al.
Publicado: (2014)

Novel Small Molecule Tyrosine Kinase 2 Pseudokinase Ligands Block Cytokine-Induced TYK2-Mediated Signaling Pathways
por: Zhou, Yu, et al.
Publicado: (2022)

Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors
por: Chambers, Andrea M, et al.
Publicado: (2022)

Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade
por: Yang, Rui, et al.
Publicado: (2020)

Research progress on GP73 in malignant tumors
por: Liang, Rong, et al.
Publicado: (2018)

Discovery of a novel IL-15 based protein with improved developability and efficacy for cancer immunotherapy
por: Hu, Qiyue, et al.
Publicado: (2018)

Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulation
por: Meziani, Lydia, et al.
Publicado: (2023)

Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors
por: Li, Huiping, et al.
Publicado: (2020)

Dopamine β-hydroxylase and p73 expression during aging and ventricular dilation in the cerebrospinal fluid and circumventricular organs of SHR rats
por: Ma Carmona-Calero, Emilia, et al.
Publicado: (2006)

Graft-versus-Host Disease Is Enhanced by Selective CD73 Blockade in Mice
por: Wang, Long, et al.
Publicado: (2013)

Blockade of Adenosine A2b Receptor Reduces Tumor Growth and Migration in Renal Cell Carcinoma
por: Yi, Ye, et al.
Publicado: (2020)

Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages – a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape
por: Montalbán del Barrio, Itsaso, et al.
Publicado: (2016)

If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice
por: Anisimov, Vladimir N., et al.
Publicado: (2011)

Roles of the Adenosine Receptor and CD73 in the Regulatory Effect of γδ T Cells
por: Liang, Dongchun, et al.
Publicado: (2014)

The Immune Regulatory Role of Adenosine in the Tumor Microenvironment
por: Xing, Jianlei, et al.
Publicado: (2023)

Feed-Forward Inhibition of CD73 and Upregulation of Adenosine Deaminase Contribute to the Loss of Adenosine Neuromodulation in Postinflammatory Ileitis
por: Vieira, Cátia, et al.
Publicado: (2014)

Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
por: Ploeg, Emily Maria, et al.
Publicado: (2023)

Blockade of Rostral Ventrolateral Medulla Apelin Receptors Does Not Attenuate Arterial Pressure in SHR and (L)-NAME-Induced Hypertensive Rats
por: Griffiths, Philip R., et al.
Publicado: (2018)

ARIH1 activates STING-mediated T-cell activation and sensitizes tumors to immune checkpoint blockade
por: Liu, Xiaolan, et al.
Publicado: (2023)

Spatial Memory in Spontaneously Hypertensive Rats (SHR)
por: Sontag, Thomas-A., et al.
Publicado: (2013)

Expression and clinical significance of p73 in Wilms tumor in children
por: Ding, Yan, et al.
Publicado: (2019)

Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
por: de Leve, Simone, et al.
Publicado: (2019)

A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine Pathway
por: Wurm, Melanie, et al.
Publicado: (2021)

Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity
por: Fu, Ziyi, et al.
Publicado: (2023)

Safety, tolerability, and pharmacokinetics of an anti-LAG-3 antibody SHR-1802 in patients with advanced solid tumors: a phase I dose-escalation and dose-expansion study
por: Deng, Ting, et al.
Publicado: (2023)

Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, in vitro and in human tumor xenograft models
por: Long, Fei, et al.
Publicado: (2019)

Cardioprotective Regimen of Adaptation to Chronic Hypoxia Diversely Alters Myocardial Gene Expression in SHR and SHR-mt(BN) Conplastic Rat Strains
por: Nedvedova, Iveta, et al.
Publicado: (2019)

Safety and Clinical Activity of SHR7390 Monotherapy or Combined With Camrelizumab for Advanced Solid Tumor: Results From Two Phase I Trials
por: Wei, Xiao-Li, et al.
Publicado: (2022)

Aerobic exercise inhibits renal EMT by promoting irisin expression in SHR
por: Luo, Minghao, et al.
Publicado: (2023)

Host CD73 impairs anti-tumor immunity
por: Salmi, Marko, et al.
Publicado: (2012)

Targeting CD73 in the tumor microenvironment with MEDI9447
por: Hay, Carl M., et al.
Publicado: (2016)

Skewed CD39/CD73/adenosine pathway contributes to B-cell hyperactivation and disease progression in patients with chronic hepatitis B
por: Zhou, Shuang-Nan, et al.
Publicado: (2020)

CD73 Dysregulates Monocyte Anti-Tumor Activity in Multiple Myeloma
por: Zhou, Lin, et al.
Publicado: (2023)

The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation
por: Roberts, Veena, et al.
Publicado: (2014)

Insufficient hypothalamic angiotensin-converting enzyme 2 is associated with hypertension in SHR rats
por: Wang, Kun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5dugi3sde2fq7r4dffnqj62vgl